

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.04886687 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.77512590 |
| 3 | vocalization behavior (GO:0071625) | 5.52949466 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.49191018 |
| 5 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.39530666 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.28871955 |
| 7 | protein localization to synapse (GO:0035418) | 5.15673514 |
| 8 | locomotory exploration behavior (GO:0035641) | 5.06282572 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 5.04883800 |
| 10 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.04558497 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.03260679 |
| 12 | glutamate receptor signaling pathway (GO:0007215) | 5.01938956 |
| 13 | synaptic transmission, glutamatergic (GO:0035249) | 5.00510604 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.99574732 |
| 15 | synaptic vesicle maturation (GO:0016188) | 4.88272799 |
| 16 | glutamate secretion (GO:0014047) | 4.79210479 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.53555344 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.51855457 |
| 19 | neuron-neuron synaptic transmission (GO:0007270) | 4.49129430 |
| 20 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.49011944 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.43864518 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.36538743 |
| 23 | long-term memory (GO:0007616) | 4.30481400 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.29085158 |
| 25 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.25563169 |
| 26 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.24959857 |
| 27 | positive regulation of membrane potential (GO:0045838) | 4.23023544 |
| 28 | exploration behavior (GO:0035640) | 4.20173363 |
| 29 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.07547120 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 4.05851344 |
| 31 | cellular sodium ion homeostasis (GO:0006883) | 4.05351063 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 4.03518013 |
| 33 | detection of calcium ion (GO:0005513) | 4.02912091 |
| 34 | regulation of postsynaptic membrane potential (GO:0060078) | 3.98372320 |
| 35 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.97100362 |
| 36 | neurotransmitter secretion (GO:0007269) | 3.91414732 |
| 37 | neuronal action potential propagation (GO:0019227) | 3.86315148 |
| 38 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.84723310 |
| 39 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.80009256 |
| 40 | neuron cell-cell adhesion (GO:0007158) | 3.78275633 |
| 41 | regulation of synapse maturation (GO:0090128) | 3.76932487 |
| 42 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.69901841 |
| 43 | behavioral fear response (GO:0001662) | 3.63936655 |
| 44 | behavioral defense response (GO:0002209) | 3.63936655 |
| 45 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.60862337 |
| 46 | synaptic vesicle endocytosis (GO:0048488) | 3.60630181 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.59835334 |
| 48 | regulation of synaptic plasticity (GO:0048167) | 3.58726713 |
| 49 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.57305787 |
| 50 | long-term synaptic potentiation (GO:0060291) | 3.56802016 |
| 51 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.52324989 |
| 52 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.51128790 |
| 53 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.50218139 |
| 54 | cellular potassium ion homeostasis (GO:0030007) | 3.47687337 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.45295865 |
| 56 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.42207349 |
| 57 | gamma-aminobutyric acid transport (GO:0015812) | 3.42096296 |
| 58 | membrane depolarization during action potential (GO:0086010) | 3.40030777 |
| 59 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.39961187 |
| 60 | proline transport (GO:0015824) | 3.39272508 |
| 61 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.37628505 |
| 62 | membrane depolarization (GO:0051899) | 3.33576262 |
| 63 | positive regulation of neurotransmitter transport (GO:0051590) | 3.32491404 |
| 64 | brain morphogenesis (GO:0048854) | 3.31993488 |
| 65 | presynaptic membrane assembly (GO:0097105) | 3.30471899 |
| 66 | response to histamine (GO:0034776) | 3.29072429 |
| 67 | neurotransmitter transport (GO:0006836) | 3.27318210 |
| 68 | presynaptic membrane organization (GO:0097090) | 3.26691495 |
| 69 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.25225779 |
| 70 | positive regulation of dendritic spine development (GO:0060999) | 3.25096388 |
| 71 | cell communication involved in cardiac conduction (GO:0086065) | 3.24886797 |
| 72 | cell communication by electrical coupling (GO:0010644) | 3.23450920 |
| 73 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.21914391 |
| 74 | fear response (GO:0042596) | 3.20084352 |
| 75 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.19292338 |
| 76 | innervation (GO:0060384) | 3.18195893 |
| 77 | transmission of nerve impulse (GO:0019226) | 3.18083546 |
| 78 | learning (GO:0007612) | 3.16349769 |
| 79 | dendritic spine organization (GO:0097061) | 3.15796828 |
| 80 | regulation of neurotransmitter transport (GO:0051588) | 3.13504273 |
| 81 | regulation of vesicle fusion (GO:0031338) | 3.13336894 |
| 82 | response to pheromone (GO:0019236) | 3.13281149 |
| 83 | calcium ion-dependent exocytosis (GO:0017156) | 3.12366800 |
| 84 | neuron recognition (GO:0008038) | 3.11439816 |
| 85 | postsynaptic membrane organization (GO:0001941) | 3.11062017 |
| 86 | striatum development (GO:0021756) | 3.09248471 |
| 87 | auditory behavior (GO:0031223) | 3.05585525 |
| 88 | membrane hyperpolarization (GO:0060081) | 3.05580005 |
| 89 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.05103545 |
| 90 | response to auditory stimulus (GO:0010996) | 3.04607756 |
| 91 | cellular ketone body metabolic process (GO:0046950) | 3.04185345 |
| 92 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.03580983 |
| 93 | synaptic transmission (GO:0007268) | 3.02910146 |
| 94 | regulation of cell communication by electrical coupling (GO:0010649) | 2.99313090 |
| 95 | long term synaptic depression (GO:0060292) | 2.99197549 |
| 96 | regulation of membrane repolarization (GO:0060306) | 2.98379230 |
| 97 | regulation of dendritic spine development (GO:0060998) | 2.97020365 |
| 98 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.95681526 |
| 99 | neuronal action potential (GO:0019228) | 2.95523126 |
| 100 | cyclic nucleotide catabolic process (GO:0009214) | 2.94500971 |
| 101 | startle response (GO:0001964) | 2.94181036 |
| 102 | cardiac conduction (GO:0061337) | 2.94092673 |
| 103 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.93227641 |
| 104 | regulation of synaptic transmission (GO:0050804) | 2.91958851 |
| 105 | positive regulation of synaptic transmission (GO:0050806) | 2.91952964 |
| 106 | cardiac muscle cell action potential (GO:0086001) | 2.91183240 |
| 107 | sodium ion export (GO:0071436) | 2.91175680 |
| 108 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.91082116 |
| 109 | potassium ion import (GO:0010107) | 2.90646734 |
| 110 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.87920231 |
| 111 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.87613941 |
| 112 | regulation of neurotransmitter levels (GO:0001505) | 2.87209707 |
| 113 | atrial cardiac muscle cell action potential (GO:0086014) | 2.86867085 |
| 114 | establishment of protein localization to Golgi (GO:0072600) | 2.86242019 |
| 115 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.85676346 |
| 116 | cAMP catabolic process (GO:0006198) | 2.83663327 |
| 117 | action potential (GO:0001508) | 2.83229363 |
| 118 | synapse assembly (GO:0007416) | 2.82443431 |
| 119 | chemosensory behavior (GO:0007635) | 2.82335277 |
| 120 | neuromuscular process controlling balance (GO:0050885) | 2.81956258 |
| 121 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.80634616 |
| 122 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.79512717 |
| 123 | regulation of female receptivity (GO:0045924) | 2.79000540 |
| 124 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.78999689 |
| 125 | mechanosensory behavior (GO:0007638) | 2.78342109 |
| 126 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.78006867 |
| 127 | adult heart development (GO:0007512) | 2.76798614 |
| 128 | acrosome reaction (GO:0007340) | 2.76171205 |
| 129 | protein targeting to Golgi (GO:0000042) | 2.74429724 |
| 130 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.73388668 |
| 131 | multicellular organismal signaling (GO:0035637) | 2.72103039 |
| 132 | cochlea development (GO:0090102) | 2.72000587 |
| 133 | relaxation of cardiac muscle (GO:0055119) | 2.71360376 |
| 134 | insulin secretion (GO:0030073) | 2.71002715 |
| 135 | ketone body metabolic process (GO:1902224) | 2.69247471 |
| 136 | central nervous system myelination (GO:0022010) | 2.68145291 |
| 137 | axon ensheathment in central nervous system (GO:0032291) | 2.68145291 |
| 138 | C4-dicarboxylate transport (GO:0015740) | 2.66310074 |
| 139 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.65214708 |
| 140 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.64030513 |
| 141 | sodium ion homeostasis (GO:0055078) | 2.63523272 |
| 142 | phosphorelay signal transduction system (GO:0000160) | 2.59158532 |
| 143 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.58551246 |
| 144 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.56779901 |
| 145 | positive regulation of action potential (GO:0045760) | 2.56188247 |
| 146 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.55372075 |
| 147 | positive regulation of sodium ion transport (GO:0010765) | 2.54321392 |
| 148 | potassium ion transmembrane transport (GO:0071805) | 2.54036880 |
| 149 | cellular potassium ion transport (GO:0071804) | 2.54036880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.47907030 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.45934642 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.91532377 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.86272029 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.82739431 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.63678417 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.61749505 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45581578 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.44879766 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43104171 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43104171 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.40085085 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30338985 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.28703345 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.28281485 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.27287751 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.26944840 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.25485948 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.24449061 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16312480 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16144583 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13219550 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.13124667 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.10739204 |
| 25 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.08718796 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.07178172 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05203442 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02282999 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.99018406 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89321424 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78975901 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.78297366 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.77784108 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.77394309 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71497677 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71352901 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64359917 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61005659 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.58277728 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56946970 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52837708 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52785167 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52178919 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50073056 |
| 45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.49246619 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47638415 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.44950352 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42004880 |
| 49 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.41558428 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.36472040 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.36036440 |
| 52 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.32979984 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.31325728 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30312818 |
| 55 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.28858223 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28724335 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28618223 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27647438 |
| 59 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26946473 |
| 60 | AR_19668381_ChIP-Seq_PC3_Human | 1.24729269 |
| 61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24224037 |
| 62 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22825522 |
| 63 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22133210 |
| 64 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.20073986 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19382346 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19225992 |
| 67 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.19035508 |
| 68 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.16052569 |
| 69 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15889693 |
| 70 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14582480 |
| 71 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.14397784 |
| 72 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14109086 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13158696 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13102417 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13102417 |
| 76 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12856780 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11914251 |
| 78 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11363759 |
| 79 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11274531 |
| 80 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09114874 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09025263 |
| 82 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08758092 |
| 83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07289633 |
| 84 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07229090 |
| 85 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.07115108 |
| 86 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07036870 |
| 87 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06626273 |
| 88 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06235507 |
| 89 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06169849 |
| 90 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06116430 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05548543 |
| 92 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04711907 |
| 93 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04711907 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04214082 |
| 95 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03526091 |
| 96 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03432477 |
| 97 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.03090176 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02961726 |
| 99 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.02764642 |
| 100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02595803 |
| 101 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02418093 |
| 102 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02324547 |
| 103 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01376959 |
| 104 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00674758 |
| 105 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00635556 |
| 106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00426592 |
| 107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00106800 |
| 108 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99520915 |
| 109 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99464427 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97033220 |
| 111 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96947344 |
| 112 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96858572 |
| 113 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96708013 |
| 114 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96708013 |
| 115 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95431772 |
| 116 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95247202 |
| 117 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94595409 |
| 118 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92982252 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 0.92883272 |
| 120 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91678436 |
| 121 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90948863 |
| 122 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90517569 |
| 123 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89333408 |
| 124 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87628732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.01645469 |
| 2 | MP0003880_abnormal_central_pattern | 4.73297641 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.14901407 |
| 4 | MP0009745_abnormal_behavioral_response | 3.61025804 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.38849612 |
| 6 | MP0004270_analgesia | 3.24778716 |
| 7 | MP0008877_abnormal_DNA_methylation | 3.19850382 |
| 8 | MP0002822_catalepsy | 3.18510572 |
| 9 | MP0002064_seizures | 3.15329062 |
| 10 | MP0009046_muscle_twitch | 3.07923966 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.85717394 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.78859179 |
| 13 | MP0001486_abnormal_startle_reflex | 2.77893639 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.68566845 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.57296568 |
| 16 | MP0002272_abnormal_nervous_system | 2.53804368 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.33089632 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.25393101 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.25079547 |
| 20 | MP0006072_abnormal_retinal_apoptosis | 2.14039455 |
| 21 | MP0002736_abnormal_nociception_after | 2.11406533 |
| 22 | MP0003879_abnormal_hair_cell | 2.11179080 |
| 23 | MP0005551_abnormal_eye_electrophysiolog | 1.93311790 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.91537185 |
| 25 | MP0001984_abnormal_olfaction | 1.88821340 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.86555589 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.79531492 |
| 28 | MP0008569_lethality_at_weaning | 1.77822861 |
| 29 | MP0004924_abnormal_behavior | 1.66162441 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.66162441 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.65042396 |
| 32 | MP0001188_hyperpigmentation | 1.63840430 |
| 33 | MP0002184_abnormal_innervation | 1.57694054 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.54461721 |
| 35 | MP0003787_abnormal_imprinting | 1.53535915 |
| 36 | MP0001970_abnormal_pain_threshold | 1.50430683 |
| 37 | MP0001485_abnormal_pinna_reflex | 1.48530657 |
| 38 | MP0000778_abnormal_nervous_system | 1.48007125 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.46330590 |
| 40 | MP0001502_abnormal_circadian_rhythm | 1.44789583 |
| 41 | MP0009780_abnormal_chondrocyte_physiolo | 1.41473897 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.38741352 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.38663551 |
| 44 | MP0003633_abnormal_nervous_system | 1.34684483 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.33808843 |
| 46 | MP0003195_calcinosis | 1.33784966 |
| 47 | MP0000955_abnormal_spinal_cord | 1.31534438 |
| 48 | MP0003329_amyloid_beta_deposits | 1.31094338 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.29809508 |
| 50 | MP0003121_genomic_imprinting | 1.28430082 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.28120199 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.22825859 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.21800272 |
| 54 | MP0004858_abnormal_nervous_system | 1.20668772 |
| 55 | MP0004142_abnormal_muscle_tone | 1.20379093 |
| 56 | MP0004084_abnormal_cardiac_muscle | 1.19083169 |
| 57 | MP0005670_abnormal_white_adipose | 1.16146309 |
| 58 | MP0005410_abnormal_fertilization | 1.14534822 |
| 59 | MP0001299_abnormal_eye_distance/ | 1.14186072 |
| 60 | MP0003283_abnormal_digestive_organ | 1.13591043 |
| 61 | MP0008775_abnormal_heart_ventricle | 1.12239959 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.10660217 |
| 63 | MP0008874_decreased_physiological_sensi | 1.10353076 |
| 64 | MP0004885_abnormal_endolymph | 1.10241328 |
| 65 | MP0001529_abnormal_vocalization | 1.10066540 |
| 66 | MP0003631_nervous_system_phenotype | 1.09640126 |
| 67 | MP0002102_abnormal_ear_morphology | 1.07895620 |
| 68 | MP0002069_abnormal_eating/drinking_beha | 1.07425081 |
| 69 | MP0004510_myositis | 1.05623549 |
| 70 | MP0001905_abnormal_dopamine_level | 1.05403675 |
| 71 | MP0006276_abnormal_autonomic_nervous | 1.04301346 |
| 72 | MP0005379_endocrine/exocrine_gland_phen | 1.04092264 |
| 73 | MP0002229_neurodegeneration | 1.03456634 |
| 74 | MP0008872_abnormal_physiological_respon | 1.02142598 |
| 75 | MP0002090_abnormal_vision | 1.01339106 |
| 76 | MP0005535_abnormal_body_temperature | 1.01309894 |
| 77 | MP0003690_abnormal_glial_cell | 0.98937439 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 0.98450756 |
| 79 | MP0002638_abnormal_pupillary_reflex | 0.97806044 |
| 80 | MP0001944_abnormal_pancreas_morphology | 0.93960257 |
| 81 | MP0005085_abnormal_gallbladder_physiolo | 0.92349515 |
| 82 | MP0002693_abnormal_pancreas_physiology | 0.90562293 |
| 83 | MP0004036_abnormal_muscle_relaxation | 0.90547456 |
| 84 | MP0001765_abnormal_ion_homeostasis | 0.90329106 |
| 85 | MP0005377_hearing/vestibular/ear_phenot | 0.89583477 |
| 86 | MP0003878_abnormal_ear_physiology | 0.89583477 |
| 87 | MP0008961_abnormal_basal_metabolism | 0.89362237 |
| 88 | MP0003075_altered_response_to | 0.87464296 |
| 89 | MP0003646_muscle_fatigue | 0.87257757 |
| 90 | MP0004043_abnormal_pH_regulation | 0.86689587 |
| 91 | MP0002152_abnormal_brain_morphology | 0.86519429 |
| 92 | MP0004147_increased_porphyrin_level | 0.86450369 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.85972994 |
| 94 | MP0005360_urolithiasis | 0.84873375 |
| 95 | MP0004085_abnormal_heartbeat | 0.83209651 |
| 96 | MP0004130_abnormal_muscle_cell | 0.82546656 |
| 97 | MP0004145_abnormal_muscle_electrophysio | 0.81482903 |
| 98 | MP0001963_abnormal_hearing_physiology | 0.80794026 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.78696969 |
| 100 | MP0004133_heterotaxia | 0.78568281 |
| 101 | MP0003123_paternal_imprinting | 0.78490592 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.76300050 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.74740470 |
| 104 | MP0009697_abnormal_copulation | 0.74160005 |
| 105 | MP0000427_abnormal_hair_cycle | 0.73305207 |
| 106 | MP0010329_abnormal_lipoprotein_level | 0.73088655 |
| 107 | MP0001177_atelectasis | 0.72664937 |
| 108 | MP0005620_abnormal_muscle_contractility | 0.72167002 |
| 109 | MP0002752_abnormal_somatic_nervous | 0.69741295 |
| 110 | MP0003632_abnormal_nervous_system | 0.69692669 |
| 111 | MP0005394_taste/olfaction_phenotype | 0.69592990 |
| 112 | MP0005499_abnormal_olfactory_system | 0.69592990 |
| 113 | MP0001986_abnormal_taste_sensitivity | 0.69375261 |
| 114 | MP0004742_abnormal_vestibular_system | 0.68419380 |
| 115 | MP0005310_abnormal_salivary_gland | 0.64815074 |
| 116 | MP0000604_amyloidosis | 0.64731186 |
| 117 | MP0005365_abnormal_bile_salt | 0.64408235 |
| 118 | MP0005253_abnormal_eye_physiology | 0.64009009 |
| 119 | MP0004019_abnormal_vitamin_homeostasis | 0.62582829 |
| 120 | MP0005332_abnormal_amino_acid | 0.62069301 |
| 121 | MP0003172_abnormal_lysosome_physiology | 0.61626161 |
| 122 | MP0000015_abnormal_ear_pigmentation | 0.59359039 |
| 123 | MP0005409_darkened_coat_color | 0.57515119 |
| 124 | MP0004484_altered_response_of | 0.55451024 |
| 125 | MP0001664_abnormal_digestion | 0.54661368 |
| 126 | MP0005171_absent_coat_pigmentation | 0.53890711 |
| 127 | MP0005195_abnormal_posterior_eye | 0.53698922 |
| 128 | MP0000631_abnormal_neuroendocrine_gland | 0.52030453 |
| 129 | MP0003122_maternal_imprinting | 0.50550933 |
| 130 | MP0005167_abnormal_blood-brain_barrier | 0.50453131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.91420507 |
| 2 | Myokymia (HP:0002411) | 6.11615150 |
| 3 | Epileptic encephalopathy (HP:0200134) | 5.42621056 |
| 4 | Febrile seizures (HP:0002373) | 5.42160908 |
| 5 | Focal seizures (HP:0007359) | 5.38736024 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.39767348 |
| 7 | Visual hallucinations (HP:0002367) | 4.38714538 |
| 8 | Hyperventilation (HP:0002883) | 3.86023740 |
| 9 | Atonic seizures (HP:0010819) | 3.78390294 |
| 10 | Absence seizures (HP:0002121) | 3.76503379 |
| 11 | Gaze-evoked nystagmus (HP:0000640) | 3.66359366 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.64643662 |
| 13 | Broad-based gait (HP:0002136) | 3.62354180 |
| 14 | Congenital stationary night blindness (HP:0007642) | 3.58176965 |
| 15 | Dialeptic seizures (HP:0011146) | 3.52311688 |
| 16 | Bundle branch block (HP:0011710) | 3.45178665 |
| 17 | Nuclear cataract (HP:0100018) | 3.38511455 |
| 18 | Poor eye contact (HP:0000817) | 3.34450658 |
| 19 | Action tremor (HP:0002345) | 3.16379048 |
| 20 | Severe visual impairment (HP:0001141) | 3.14912925 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.10754379 |
| 22 | Postural instability (HP:0002172) | 3.00255463 |
| 23 | Impaired smooth pursuit (HP:0007772) | 2.97576745 |
| 24 | Atrial fibrillation (HP:0005110) | 2.89135385 |
| 25 | Double outlet right ventricle (HP:0001719) | 2.88908217 |
| 26 | Congenital malformation of the right heart (HP:0011723) | 2.88908217 |
| 27 | Depression (HP:0000716) | 2.87502568 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.87216835 |
| 29 | Impaired social interactions (HP:0000735) | 2.85731645 |
| 30 | Abnormal social behavior (HP:0012433) | 2.85731645 |
| 31 | Scanning speech (HP:0002168) | 2.84386785 |
| 32 | Fair hair (HP:0002286) | 2.84224004 |
| 33 | Dysmetria (HP:0001310) | 2.79167410 |
| 34 | Truncal ataxia (HP:0002078) | 2.73646815 |
| 35 | Abnormal eating behavior (HP:0100738) | 2.73498033 |
| 36 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.72521148 |
| 37 | Absent/shortened dynein arms (HP:0200106) | 2.72521148 |
| 38 | Central scotoma (HP:0000603) | 2.71181661 |
| 39 | Epileptiform EEG discharges (HP:0011182) | 2.69764545 |
| 40 | Ventricular fibrillation (HP:0001663) | 2.69605108 |
| 41 | Primary atrial arrhythmia (HP:0001692) | 2.69447451 |
| 42 | Genetic anticipation (HP:0003743) | 2.68293370 |
| 43 | Abnormality of the lower motor neuron (HP:0002366) | 2.67570071 |
| 44 | Anxiety (HP:0000739) | 2.67118677 |
| 45 | Status epilepticus (HP:0002133) | 2.67089646 |
| 46 | * Hyperkalemia (HP:0002153) | 2.66626994 |
| 47 | Thyroiditis (HP:0100646) | 2.63910646 |
| 48 | Drooling (HP:0002307) | 2.62594700 |
| 49 | Excessive salivation (HP:0003781) | 2.62594700 |
| 50 | Protruding tongue (HP:0010808) | 2.61636186 |
| 51 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.59710879 |
| 52 | Dysmetric saccades (HP:0000641) | 2.57416211 |
| 53 | Sudden death (HP:0001699) | 2.55697396 |
| 54 | Increased circulating renin level (HP:0000848) | 2.54687676 |
| 55 | Intestinal atresia (HP:0011100) | 2.53602552 |
| 56 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.53507859 |
| 57 | Fetal akinesia sequence (HP:0001989) | 2.51425731 |
| 58 | Generalized hypopigmentation of hair (HP:0011358) | 2.50808263 |
| 59 | Limb dystonia (HP:0002451) | 2.50171634 |
| 60 | Torticollis (HP:0000473) | 2.50094133 |
| 61 | Supraventricular tachycardia (HP:0004755) | 2.49730456 |
| 62 | Focal dystonia (HP:0004373) | 2.48315709 |
| 63 | Bradykinesia (HP:0002067) | 2.48172733 |
| 64 | Hyperactive renin-angiotensin system (HP:0000841) | 2.44828294 |
| 65 | Hemiparesis (HP:0001269) | 2.44341471 |
| 66 | Supraventricular arrhythmia (HP:0005115) | 2.43341732 |
| 67 | Gait imbalance (HP:0002141) | 2.43076029 |
| 68 | EEG with generalized epileptiform discharges (HP:0011198) | 2.41446644 |
| 69 | Heart block (HP:0012722) | 2.40748234 |
| 70 | Pancreatic fibrosis (HP:0100732) | 2.40218980 |
| 71 | Stereotypic behavior (HP:0000733) | 2.39350371 |
| 72 | Mutism (HP:0002300) | 2.37883300 |
| 73 | Supranuclear gaze palsy (HP:0000605) | 2.37844834 |
| 74 | Aqueductal stenosis (HP:0002410) | 2.36874806 |
| 75 | Hematochezia (HP:0002573) | 2.36117694 |
| 76 | Blue irides (HP:0000635) | 2.35281710 |
| 77 | Impaired vibratory sensation (HP:0002495) | 2.34466187 |
| 78 | Colon cancer (HP:0003003) | 2.33423538 |
| 79 | Absent speech (HP:0001344) | 2.32457166 |
| 80 | Decreased circulating renin level (HP:0003351) | 2.28840831 |
| 81 | Attenuation of retinal blood vessels (HP:0007843) | 2.28015556 |
| 82 | Palpitations (HP:0001962) | 2.27222757 |
| 83 | Diplopia (HP:0000651) | 2.26454629 |
| 84 | Abnormality of binocular vision (HP:0011514) | 2.26454629 |
| 85 | Abnormality of the labia minora (HP:0012880) | 2.23719286 |
| 86 | Abnormal drinking behavior (HP:0030082) | 2.22860944 |
| 87 | Polydipsia (HP:0001959) | 2.22860944 |
| 88 | Hemiplegia (HP:0002301) | 2.19619016 |
| 89 | Amblyopia (HP:0000646) | 2.18689972 |
| 90 | Hypsarrhythmia (HP:0002521) | 2.18559626 |
| 91 | Abnormality of macular pigmentation (HP:0008002) | 2.17119236 |
| 92 | Inability to walk (HP:0002540) | 2.16952266 |
| 93 | Decreased central vision (HP:0007663) | 2.16775812 |
| 94 | Toxemia of pregnancy (HP:0100603) | 2.16452714 |
| 95 | Nephronophthisis (HP:0000090) | 2.14918765 |
| 96 | Ankle clonus (HP:0011448) | 2.13093970 |
| 97 | Congenital primary aphakia (HP:0007707) | 2.11532592 |
| 98 | Medial flaring of the eyebrow (HP:0010747) | 2.10578959 |
| 99 | Hypomagnesemia (HP:0002917) | 2.10263181 |
| 100 | Nephrogenic diabetes insipidus (HP:0009806) | 2.09620655 |
| 101 | Craniofacial dystonia (HP:0012179) | 2.09361058 |
| 102 | Ketoacidosis (HP:0001993) | 2.05787077 |
| 103 | * Abnormality of potassium homeostasis (HP:0011042) | 2.05444891 |
| 104 | Polyphagia (HP:0002591) | 2.04851438 |
| 105 | Intention tremor (HP:0002080) | 2.04570535 |
| 106 | True hermaphroditism (HP:0010459) | 2.02479068 |
| 107 | Abnormal EKG (HP:0003115) | 1.98693822 |
| 108 | Incomplete penetrance (HP:0003829) | 1.97956456 |
| 109 | Pancreatic cysts (HP:0001737) | 1.97171262 |
| 110 | Metabolic alkalosis (HP:0200114) | 1.96493425 |
| 111 | Abolished electroretinogram (ERG) (HP:0000550) | 1.95869656 |
| 112 | Metaphyseal dysplasia (HP:0100255) | 1.95333730 |
| 113 | Agitation (HP:0000713) | 1.95080274 |
| 114 | Abnormal atrioventricular conduction (HP:0005150) | 1.94500535 |
| 115 | Papilledema (HP:0001085) | 1.91545981 |
| 116 | Abnormality of vitamin B metabolism (HP:0004340) | 1.91075418 |
| 117 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90996925 |
| 118 | Abnormality of alanine metabolism (HP:0010916) | 1.90996925 |
| 119 | Hyperalaninemia (HP:0003348) | 1.90996925 |
| 120 | Abnormal ciliary motility (HP:0012262) | 1.90913663 |
| 121 | Severe combined immunodeficiency (HP:0004430) | 1.90303608 |
| 122 | Hypothermia (HP:0002045) | 1.88330221 |
| 123 | Ventricular arrhythmia (HP:0004308) | 1.86910864 |
| 124 | Abnormality of renin-angiotensin system (HP:0000847) | 1.86163389 |
| 125 | Spinal canal stenosis (HP:0003416) | 1.86026454 |
| 126 | Testicular atrophy (HP:0000029) | 1.84837434 |
| 127 | Hyperaldosteronism (HP:0000859) | 1.82328518 |
| 128 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.82096404 |
| 129 | Limb ataxia (HP:0002070) | 1.81041556 |
| 130 | Palpebral edema (HP:0100540) | 1.80500935 |
| 131 | Poor coordination (HP:0002370) | 1.80284915 |
| 132 | Unsteady gait (HP:0002317) | 1.80089519 |
| 133 | Abnormality of saccadic eye movements (HP:0000570) | 1.78476384 |
| 134 | Spastic gait (HP:0002064) | 1.78035889 |
| 135 | Atrioventricular block (HP:0001678) | 1.77641846 |
| 136 | Psychosis (HP:0000709) | 1.77358135 |
| 137 | Tubulointerstitial nephritis (HP:0001970) | 1.77235006 |
| 138 | Methylmalonic acidemia (HP:0002912) | 1.76386643 |
| 139 | Abnormality of the renal medulla (HP:0100957) | 1.76017517 |
| 140 | Oligodactyly (hands) (HP:0001180) | 1.75359629 |
| 141 | Optic nerve hypoplasia (HP:0000609) | 1.74205329 |
| 142 | Abnormality of the renal cortex (HP:0011035) | 1.70067345 |
| 143 | Glucose intolerance (HP:0000833) | 1.69472054 |
| 144 | Chronic hepatic failure (HP:0100626) | 1.68693482 |
| 145 | Spastic tetraparesis (HP:0001285) | 1.66158120 |
| 146 | Abnormality of salivation (HP:0100755) | 1.65852588 |
| 147 | Syncope (HP:0001279) | 1.65448383 |
| 148 | Abnormality of the periventricular white matter (HP:0002518) | 1.65189020 |
| 149 | Prolonged QT interval (HP:0001657) | 1.65144866 |
| 150 | Retinal atrophy (HP:0001105) | 1.64613978 |
| 151 | Generalized myoclonic seizures (HP:0002123) | 1.64264119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.17653207 |
| 2 | EPHA4 | 4.88970896 |
| 3 | NTRK3 | 4.56470466 |
| 4 | MAP2K7 | 3.20685325 |
| 5 | MARK1 | 3.06651172 |
| 6 | PRPF4B | 2.94400630 |
| 7 | RIPK4 | 2.87714304 |
| 8 | MAP3K4 | 2.83736131 |
| 9 | FGFR2 | 2.68655483 |
| 10 | DAPK2 | 2.50087319 |
| 11 | MAP3K9 | 2.45646425 |
| 12 | TIE1 | 2.31477499 |
| 13 | TNIK | 2.29499587 |
| 14 | SIK3 | 2.24187092 |
| 15 | MINK1 | 2.22139664 |
| 16 | CASK | 2.09990340 |
| 17 | DAPK1 | 1.98446298 |
| 18 | NTRK2 | 1.94457300 |
| 19 | NLK | 1.92638119 |
| 20 | PAK6 | 1.92248875 |
| 21 | CAMKK1 | 1.88762337 |
| 22 | EEF2K | 1.82488675 |
| 23 | SIK2 | 1.81344585 |
| 24 | MAP2K4 | 1.71712051 |
| 25 | KSR1 | 1.67920734 |
| 26 | STK38 | 1.67198020 |
| 27 | FES | 1.55475774 |
| 28 | SGK2 | 1.49287799 |
| 29 | MAP3K12 | 1.49062479 |
| 30 | CAMKK2 | 1.42211682 |
| 31 | CDK5 | 1.41726552 |
| 32 | BMPR2 | 1.40889553 |
| 33 | MAPKAPK3 | 1.40622010 |
| 34 | PLK2 | 1.36609217 |
| 35 | MAP3K13 | 1.35370407 |
| 36 | PRKD3 | 1.30947914 |
| 37 | CAMK1 | 1.30302517 |
| 38 | TAOK2 | 1.29947847 |
| 39 | MAP4K2 | 1.28445007 |
| 40 | TRPM7 | 1.26968004 |
| 41 | PRKCG | 1.26659851 |
| 42 | MAPK13 | 1.21790894 |
| 43 | PTK2B | 1.18904705 |
| 44 | SGK223 | 1.18304003 |
| 45 | SGK494 | 1.18304003 |
| 46 | TAOK3 | 1.18250836 |
| 47 | PINK1 | 1.16401325 |
| 48 | GRK5 | 1.13181789 |
| 49 | OBSCN | 1.10880167 |
| 50 | ITK | 1.06027104 |
| 51 | SGK3 | 1.02519949 |
| 52 | MKNK2 | 1.01328589 |
| 53 | WNK1 | 1.00562339 |
| 54 | KSR2 | 1.00329934 |
| 55 | NTRK1 | 0.99505281 |
| 56 | CAMK2A | 0.98354323 |
| 57 | TEC | 0.95977244 |
| 58 | NUAK1 | 0.95902460 |
| 59 | BMPR1B | 0.94537918 |
| 60 | OXSR1 | 0.90421292 |
| 61 | MAPKAPK5 | 0.85373993 |
| 62 | RAF1 | 0.85362432 |
| 63 | ARAF | 0.85231985 |
| 64 | INSRR | 0.84090169 |
| 65 | PDK2 | 0.83895158 |
| 66 | CAMK2B | 0.82600105 |
| 67 | SGK1 | 0.82593265 |
| 68 | CAMK4 | 0.80497338 |
| 69 | MAP3K7 | 0.80290891 |
| 70 | NEK6 | 0.78511647 |
| 71 | DYRK1A | 0.72226641 |
| 72 | AKT3 | 0.70005231 |
| 73 | STK38L | 0.69560240 |
| 74 | WNK3 | 0.69294841 |
| 75 | PRKCH | 0.69225758 |
| 76 | GRK1 | 0.69107017 |
| 77 | TXK | 0.68331199 |
| 78 | PDK1 | 0.67634537 |
| 79 | TNK2 | 0.65521181 |
| 80 | PLK4 | 0.64696257 |
| 81 | MARK2 | 0.61362968 |
| 82 | CDK19 | 0.57527477 |
| 83 | FGFR3 | 0.55729043 |
| 84 | CDK18 | 0.55465171 |
| 85 | STK11 | 0.55031910 |
| 86 | PRKCZ | 0.53340285 |
| 87 | STK39 | 0.53236491 |
| 88 | DMPK | 0.53000611 |
| 89 | PRKCE | 0.52085216 |
| 90 | PIK3CG | 0.50185637 |
| 91 | PNCK | 0.49804218 |
| 92 | PDPK1 | 0.49090556 |
| 93 | BRD4 | 0.48478285 |
| 94 | CDK15 | 0.48049920 |
| 95 | WNK4 | 0.47820360 |
| 96 | TAOK1 | 0.47133304 |
| 97 | MAPK7 | 0.46656486 |
| 98 | PRKAA2 | 0.46400350 |
| 99 | PHKG1 | 0.45776532 |
| 100 | PHKG2 | 0.45776532 |
| 101 | RPS6KA3 | 0.45519978 |
| 102 | MUSK | 0.45338728 |
| 103 | CCNB1 | 0.45234902 |
| 104 | PKN1 | 0.45061610 |
| 105 | PRKAA1 | 0.44763967 |
| 106 | MAPK12 | 0.43342164 |
| 107 | PRKACB | 0.42227444 |
| 108 | CDK11A | 0.40732927 |
| 109 | YES1 | 0.40592331 |
| 110 | PIK3CA | 0.39835077 |
| 111 | FYN | 0.39438448 |
| 112 | ACVR1B | 0.39005604 |
| 113 | UHMK1 | 0.37519698 |
| 114 | PRKG1 | 0.37414607 |
| 115 | MAP2K6 | 0.37354480 |
| 116 | MAP3K1 | 0.37159707 |
| 117 | ROCK2 | 0.37016109 |
| 118 | CDK3 | 0.36930372 |
| 119 | ALK | 0.36768226 |
| 120 | CSNK1G2 | 0.36747005 |
| 121 | CAMK2D | 0.36257814 |
| 122 | ADRBK2 | 0.35189027 |
| 123 | CAMK2G | 0.35046206 |
| 124 | MAPK10 | 0.34931304 |
| 125 | CSNK1G1 | 0.34777817 |
| 126 | PRKCB | 0.34575854 |
| 127 | PAK3 | 0.34396876 |
| 128 | PRKCA | 0.34141789 |
| 129 | CDK14 | 0.32048590 |
| 130 | CDC42BPA | 0.31848293 |
| 131 | CAMK1G | 0.31658260 |
| 132 | PRKACA | 0.29927666 |
| 133 | RET | 0.29064219 |
| 134 | BRSK1 | 0.28403020 |
| 135 | FGR | 0.28295459 |
| 136 | MAP3K6 | 0.27834515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.74776310 |
| 2 | Circadian entrainment_Homo sapiens_hsa04713 | 3.11867878 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.09362054 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.04752819 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.91757516 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.89954630 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.89752942 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.83343890 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.64407178 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.45716754 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.32393557 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.23286229 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.06912642 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.05400529 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.97477464 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.92979208 |
| 17 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.90060689 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.88391611 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.84776021 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82601316 |
| 21 | Phototransduction_Homo sapiens_hsa04744 | 1.82450109 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.69460894 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.64429001 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62156584 |
| 25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.61963276 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.47663766 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39122418 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.36346134 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.35510468 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.35305298 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.33890566 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32059162 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30117854 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.24608757 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24458790 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17070994 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.16858402 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10047713 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08092288 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06394237 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04904733 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03171967 |
| 43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99137553 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95015753 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93782424 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91486170 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.90189198 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87780213 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86028499 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83153667 |
| 51 | Gap junction_Homo sapiens_hsa04540 | 0.82243448 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.82169805 |
| 53 | Axon guidance_Homo sapiens_hsa04360 | 0.80438798 |
| 54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.79633082 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79221410 |
| 56 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.76408414 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 0.75568437 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75234007 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74735921 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73041659 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71177488 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70481731 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.70016867 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69807924 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67092299 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65768932 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64923507 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64017012 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63977357 |
| 70 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63197546 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60756153 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59690961 |
| 73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59437047 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58172852 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57423876 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57309972 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.53784305 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53327964 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53285897 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52900439 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52696055 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51051962 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50583008 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47786084 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46321768 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44940311 |
| 87 | Tight junction_Homo sapiens_hsa04530 | 0.44542050 |
| 88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42022125 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41338702 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39476370 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.38445142 |
| 92 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38410848 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.38175343 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38149825 |
| 95 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37959987 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35259799 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34947132 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.34100657 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33950081 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.33819140 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32969681 |
| 102 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32276663 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29977231 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29791840 |
| 105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29767114 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.28120200 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25704242 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25121806 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24891157 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.24811773 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24473853 |
| 112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.23255841 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22554683 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22447648 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21783152 |
| 116 | Peroxisome_Homo sapiens_hsa04146 | 0.20648085 |
| 117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20341325 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.19951549 |
| 119 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.18541344 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18021383 |
| 121 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.17850447 |
| 122 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16703480 |

